Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Valsecchi

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Blood|January 3, 2012
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group studyHuining Kang, Carla S Wilson, Richard C Harvey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 4, 2020
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2020
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohortAlessandro Soria, Marco Fava, Davide P Bernasconi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
Blood|January 3, 2012
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group studyHuining Kang, Carla S Wilson, Richard C Harvey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coinP Alberti, E Rossi, D R Cornblath, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 4, 2020
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Oncotarget|July 25, 2016
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemiaChiara Palmi, Angela M Savino, Daniela Silvestri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2012
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findingsG Cavaletti, D R Cornblath, I S J Merkies, et al.
The New England Journal of Medicine|November 17, 2021
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeBernhard Gentner, Francesca Tucci, Stefania Galimberti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2020
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohortAlessandro Soria, Marco Fava, Davide P Bernasconi, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Pageof 11